Safety and efficacy of a 3 mg dose of the GnRH antagonist cetrorelix in preventing premature LH surges: report of two large multicentre, multinational, phase IIIb clinical experiences

Author： Olivennes F   Diedrich K   Frydman R   Felberbaum RE   Howles CM  

Publisher： Reproductive Healthcare Ltd

ISSN： 1472-6483

Source： Reproductive BioMedicine Online, Vol.6, Iss.4, 2003-06, pp. : 432-438

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment

By Roulier Roger   Chabert-Orsini Véronique   Sitri Marie-Christine   Barry Bernard   Terriou P  

Reproductive BioMedicine Online, Vol. 7, Iss. 2, 2003-09 ,pp. : 185-189

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

By Sauer Mark V   Thornton Melvin H   Schoolcraft William   Frishman Gary N  

Reproductive BioMedicine Online, Vol. 9, Iss. 5, 2004-11 ,pp. : 487-493

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

High-dose recombinant LH add-back strategy using high-dose GnRH antagonist is an innovative protocol compared with standard GnRH antagonist

By Garcia-Velasco JA   Coelingh Bennink HJT   Epifanio R   Escudero E   Pellicer A   Simón C  

Reproductive BioMedicine Online, Vol. 15, Iss. 3, 2007-09 ,pp. : 280-287

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Single-dose GnRH agonist administration in the luteal phase of GnRH antagonist cycles: a prospective randomized study

By Isik AZ   Caglar GS   Sozen E   Akarsu C   Tuncay G   Ozbıcer T   Vicdan K  

Reproductive BioMedicine Online, Vol. 19, Iss. 4, 2009-10 ,pp. : 472-477

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles - a prospective, randomized study

By Vlaisavljevic Veljko   Reljic Milan   Lovrec Vida Gavric   Kovacic Borut  

Reproductive BioMedicine Online, Vol. 7, Iss. 3, 2003-10 ,pp. : 301-308

Reproductive Healthcare Ltd

Access to resources Recommend Favorite